BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 35123859)

  • 1. Long disease-free interval diminishes the prognostic value of primary tumor stage for patients with colorectal cancer liver metastases.
    Liu JM; Wang YY; Liu W; Xu D; Wang K; Xing BC
    HPB (Oxford); 2022 May; 24(5):737-748. PubMed ID: 35123859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival.
    Höppener DJ; Nierop PMH; van Amerongen MJ; Olthof PB; Galjart B; van Gulik TM; de Wilt JHW; Grünhagen DJ; Rahbari NN; Verhoef C
    Ann Surg Oncol; 2019 Sep; 26(9):2812-2820. PubMed ID: 31147988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tumour size ratio on liver recurrence-free survival of patients undergoing hepatic resection for colorectal liver metastases.
    Zhai Y; Bai W; Zhou J; Dong Q; Zhang J
    BMC Cancer; 2022 Jan; 22(1):103. PubMed ID: 35078439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis.
    Zhang Y; Wang Y; Yuan Y; Qiu J; Qiu Y; He W; Zheng Y; Wang Z; Gu Y; Lu Z; Chen G; Ding P; Wu X; Pan Z; Wan D; Li Y; Xu R; Yuan Y; Li B
    World J Surg Oncol; 2020 May; 18(1):98. PubMed ID: 32423450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.
    Passot G; Chun YS; Kopetz SE; Overman MJ; Conrad C; Aloia TA; Vauthey JN
    Eur J Surg Oncol; 2016 Sep; 42(9):1378-84. PubMed ID: 27358198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact of Adjuvant Chemotherapy after Hepatic Resection for Synchronous and Early Metachronous Colorectal Liver Metastases.
    Nishioka Y; Moriyama J; Matoba S; Kuroyanagi H; Hashimoto M; Shindoh J
    Dig Surg; 2018; 35(3):187-195. PubMed ID: 28848205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical outcomes after resection of both hepatic and pulmonary metastases from colorectal cancer.
    Sakamoto Y; Sakaguchi Y; Oki E; Minami K; Toh Y; Okamura T
    World J Surg; 2012 Nov; 36(11):2708-13. PubMed ID: 22782440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APC and PIK3CA Mutational Cooperativity Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colorectal Liver Metastases.
    Yamashita S; Chun YS; Kopetz SE; Maru D; Conrad C; Aloia TA; Vauthey JN
    Ann Surg; 2020 Dec; 272(6):1080-1085. PubMed ID: 28379870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
    Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The time interval between primary colorectal carcinoma resection to occurrence of liver metastases is the most important factor for hepatic resection. Analysis of total course following primary resection of colorectal cancer.
    Sato T; Konishi K; Yabushita K; Nojima N; Kimura H; Maeda K; Tsuji M; Miwa A
    Int Surg; 1998; 83(4):340-2. PubMed ID: 10096757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Perioperative Red Blood Cell Transfusions on Long-Term Outcomes after Hepatectomy for Colorectal Liver Metastases.
    Hallet J; Tsang M; Cheng ES; Habashi R; Kulyk I; Hanna SS; Coburn NG; Lin Y; Law CH; Karanicolas PJ
    Ann Surg Oncol; 2015 Nov; 22(12):4038-45. PubMed ID: 25752895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the difficulty grade of laparoscopic liver resection for colorectal liver metastases correlate with long-term outcomes?
    Hołówko W; Triantafyllidis I; Neuberg M; Tabchouri N; Beaussier M; Bennamoun M; Sarran A; Lefevre M; Louvet C; Gayet B; Fuks D
    Eur J Surg Oncol; 2020 Sep; 46(9):1620-1627. PubMed ID: 32561203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined resection and RFA in colorectal liver metastases: stratification of long-term outcomes.
    Sasaki K; Margonis GA; Andreatos N; Kim Y; Wilson A; Gani F; Amini N; Pawlik TM
    J Surg Res; 2016 Nov; 206(1):182-189. PubMed ID: 27916360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases.
    Okuno M; Goumard C; Mizuno T; Kopetz S; Omichi K; Tzeng CD; Chun YS; Lee JE; Vauthey JN; Conrad C
    Br J Surg; 2018 Aug; 105(9):1200-1209. PubMed ID: 29664996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Circulating Tumor Cells at Surgery and at Follow-Up Assessment to Predict Survival After Two-Stage Liver Resection of Colorectal Liver Metastases.
    Brudvik KW; Seeberg LT; Hugenschmidt H; Renolen A; Schirmer CB; Brunborg C; Bjørnbeth BA; Borgen E; Naume B; Waage A; Wiedswang G
    Ann Surg Oncol; 2015 Nov; 22(12):4029-37. PubMed ID: 25801354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.
    Mizuno T; Cloyd JM; Vicente D; Omichi K; Chun YS; Kopetz SE; Maru D; Conrad C; Tzeng CD; Wei SH; Aloia TA; Vauthey JN
    Eur J Surg Oncol; 2018 May; 44(5):684-692. PubMed ID: 29551247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.
    Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J
    Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of
    Shim JR; Lee SD; Han SS; Lee SJ; Lee DE; Kim SK; Kim SH; Park SJ; Oh JH
    Eur J Surg Oncol; 2018 May; 44(5):670-676. PubMed ID: 29459018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.